Merck announced ACIP voted to recommend Enflosnia (clesrovimab-cfor) as a treatment option for RSV in infants younger than 8 months of age who are born during or entering their first RSV season.

The long-term health care industry is facing a double whammy from President Donald Trump’s crackdown on immigrants and the ...

Yet despite the increased efforts from various health brands to raise awareness around menopause, both HCPs and patients ...

Nearly seven months after the fatal shooting of an insurance CEO in New York drew widespread attention to health insurers’ ...

GOP lawmakers want to nationalize Medicaid work requirements to offset Trump’s proposed tax cuts. Yet Georgia’s example shows that this could threaten health care for nearly 16 million Americans and ...

Earlier this week, the pharma giant publicly accused Hims & Hers of “deceptive” marketing that is putting patient safety at risk.

California lawmakers are poised to delay the state’s much-ballyhooed new law mandating in vitro fertilization insurance coverage for millions, set to take effect July 1.

Some leading vaccine scientists are calling for more resources to research vaccine safety and support people with claims of injury — and asking Kennedy, who has a history as an anti-vaccine activist, ...